Skip to main content
. Author manuscript; available in PMC: 2022 Oct 1.
Published in final edited form as: Disabil Health J. 2021 Jun 11;14(4):101133. doi: 10.1016/j.dhjo.2021.101133

Table 1:

Participant demographics and clinical characteristics for adults with multiple sclerosis (N = 290).

Mean (Standard Deviation) Range
Age (years) 52.2 (12.1) 22-78
Sex (n (%)) 238 (82)F / 51 (18)M
Race (n (%))
Caucasian 231 (80)
Black/African American 46 (16)
Latino/Latina 6 (2)
Other 5 (2)
MS Type (n (%))
Relapsing Remitting MS 262 (90)
Secondary Progressive MS 13 (5)
Primary Progressive MS 6 (2)
Benign 5 (2)
Disease Duration (years) 15.0 (9.2) 0.5-48.0
PDDS (median [IQR]) 1 [2] 0-3

Sleep Parameters
PSQI Global Score 7.5 (3.8) 0.0-18.0
Poor Sleepers (n (%)) 223 (77)
Total Time in Bed (hours) 8.3 (1.3) 4.0-12.5
Sleep Duration (hours) 7.0 (1.4) 2.5-12.0
Sleep Efficiency (%) 84.8 (14.8) 31.8-125.0
Sleep Onset Latency (min) 26.0 (26.4) 0.0-210.0

Accelerometry Parameters
Average Accelerometer Wear Time 823.0 (87.1) 627.0-1228.3
Sedentary Behavior (min/day) 510.2 (94.0) 237.4-830.8
% Sedentary Time 62.1 (9.8) 25.7-86.6
LPA (min/day) 289.6 (81.8) 96.0-607.8
% Time in LPA 35.1 (9.0) 13.3-63.9
MVPA (min/day) 23.3 (22.0) 0.2-145.0
% Time MVPA 2.8 (2.5) 0.0-15.6

Note: Data are presented as mean (standard deviation) unless otherwise specified. MS multiple sclerosis; PDDS Patient Determined Disease Status; IQR interquartile range; PSQI Pittsburgh Sleep Quality Index; LPA light physical activity; MVPA moderate-to-vigorous physical activity.